{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.9","upperLimit":"6.9","value":"5.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"}],"units":"Participants"}],"description":"Duration of response (DOR) defined as the period from first Partial Response (PR) and Complete Response (CR) assessment till first assessment of progressive disease or death. Response assessed by Computed Tomography (CT) by Independent Review Committee (IRC).","dispersionType":"95% Confidence Interval","groups":[{"description":"Subjects with Relapsed or Refractory CD30 positive Peripheral T-cell Lymphoma (PTCL).","id":"OG000","title":"Cohort A"}],"paramType":"MEDIAN","populationDescription":"All subjects of the full analysis set (FAS) who had a response in CT assessed by IRC.","reportingStatus":"POSTED","timeFrame":"Tumor assessment performed every 8 weeks for first 3 assessments, then every 12 weeks until documented disease progression (up to 46 months).","title":"Duration of Overall Response Assessed by Independent Review Committee Based on CT","type":"SECONDARY","unitOfMeasure":"months"}